[Indication] For the treatment of essential hypertension
[Indication] For the maintenance of remission therapy of ulcerative colitis in adults
[Indication] Type 2 diabetes
[Indication] Depression
Home
Previous
A total of 5 page 30 data
Focus on foyou
Company profile
Molecular company
Production quality
Enterprise culture
Enterprise honor
Contact us
Product center
Marketing system
Company dynamic
Media reports
R&D strength
Responsible care
Green development
Social Responsibility Report
Corporate governance
Company announcement
Investor interaction
Growth path
Employee benefits
Employees story
COPYRIGHT Beijing foyou Pharmaceutical Co., LTD. All rights reserved Beijing ICP 10216134-3
Internet drug information service qualification certificate :(Beijing) - non-operational -2022-00575
COPYRIGHT Beijing foyou Pharmaceutical Co., LTD. All rights reserved
<abbr id="iii2w"></abbr>
EN
